CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Clinical trials for CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial: engineered immune cells battle deadly heart shock
Disease control Not yet recruitingThis early-stage study is testing a new cell therapy for people who have a severe heart attack that leads to cardiogenic shock, a dangerous condition where the heart can't pump enough blood. Researchers are giving patients specially engineered immune cells from healthy donors, de…
Matched conditions: CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Hong kong launches major heart shock registry to track Life-Saving pump outcomes
Knowledge-focused Not yet recruitingThis study is a registry that aims to understand the real-world outcomes for heart attack patients who develop severe, life-threatening shock in Hong Kong. It will track and compare patients who receive mechanical heart pump support with those who do not, to see how these devices…
Matched conditions: CARDIOGENIC SHOCK POST MYOCARDIAL INFARCTION
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC